Taking a comprehensive approach to executing our “U.S.-first”
#strategy is discussed by Victor Bulto.
This focus includes early research, drug profile selection, clinical development, commercialization and patient services.
@FiercePharma #Investors #JPM23 t.co/cDLafgDIEM